Radioimmunoassay market is projected to witness significant growth over the forecast period, owing to rising prevalence of various infectious diseases and cancer.
Radioimmunoassay (RIA) is one of the most frequently used in-vitro assay techniques to measure the concentration of antigens in blood. The principle on which radioimmunoassay based on competitive binding assay. In this technique, antibody and antigen bind to one another and the amount of bound antigen is measured using radioimmunoassay. This method is hypersensitive in nature and can measure even the smallest amount of hormone or drug level with the help of antibodies. Immunoassays play a significant role in the analysis of various clinical laboratory analytes such as nucleic acid, hormones, proteins, and drugs. The development of assays with much more sensitivity will lead to the discovery of new biomarkers for diagnosis of diseases.
Click To Continue Reading on Radioimmunoassay Market
Over the years, the importance of radioimmunoassay in the field of medical diagnostics has increased due to various factors such as specificity of results, accuracy, sensitivity, and precision. The three main factors involved in radioimmunoassay include bound antigen, a radio labelled antigen, and a pure antigen, along with a separation unit to estimate the delivery of radioactivity in free and bound antigens. Radioimmunoassay methods are used in several fields of disease diagnosis such as in early detection and diagnosis of cancer, other chronic diseases, and diagnosis of neurodegenerative disorders. In biotechnology and pharmaceutical industry, radioimmunoassay is used for drug testing.
On the basis of region, radioimmunoassay market is segmented into North America, Europe, Latin America, Asia Pacific, Middle East, and Africa. North America holds dominant position in the market, owing to rising adoption of technologically advanced devices, awareness among the people, high infection rates, better medical facilities, and rising adoption of innovative products. Moreover, government support towards the infection-free states is also increasing growth of radioimmunoassay market. For instance, according to 2015 National Ambulatory Medical Care survey, 16.8 million number of visits to physician offices for infectious and parasitic diseases were recorded.
Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/1770
Asia Pacific is expected to witness significant growth in the market over the forecast period, owing to large number of population vulnerable to various chronic diseases and increasing healthcare research activities.
Key Vendors:
DRG international, Inc., DIAsource ImmunoAssays, IBL Internationa, MP Biomedicals, Beckman Coulter, Inc., PerkinElmer, Inc., Dia Dorin S.p.A., Cisbi, EMD Millipore, Berthold Technologies GmbH, LLC, Euro Diagnostica, and Izotop.
Contact Us:
Mr. ShahCoherent Market Insights1001 4th Ave, #3200Seattle, WA 98154Tel: +1-206-701-6702Email: sales@coherentmarketinsights.com
Visit our news Website: https://www.coherenttimes.org/
Aspergillosis Treatment Market Opportunity Analysis, 2018-2026
Patent expiration of branded products and drug resistance to antifungal medications are the factors restraining growth of the market.Measles Mumps and Rubella (MMR) Vaccines Market Opportunity Analysis, 2018 – 2026
Vaccine manufacturers are focusing on partnering with organizations such WHO, UNICEF, and GAVI Alliance to improve their vaccination programs, in order to reach the maximum population to offer vaccines.PoC Platform & Technology Market to Surpass US$ 45.4 Billion by 2025
The global POC platform & technology market was valued at US$ 21,370.3 Million in 2016 and is expected to exhibit a robust CAGR of 8.9% over the forecast period (2017 – 2025).